Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weichang Yang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Biological Macromolecules|May 11, 2026
Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infectionHongquan Xing, Shanshan Cai, Cong Wu, et al.
World Journal of Surgical Oncology|November 1, 2025
Primary tumor resection: a new hope or an old illusion for patients with metastatic non-small cell lung neuroendocrine tumors?Hongquan Xing, Weichang Yang, Shanshan Cai, et al.
Plos One|November 8, 2024
Clinical features and prognostic factors of IV combined small cell lung cancer: A propensity score matching analysisShanshan Cai, Weichang Yang, Hongdan Luo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2024
ApoA1, ApoB, ApoA1/B for Pathogenic Prediction of Chronic Obstructive Pulmonary Disease Complicated by Acute Lower Respiratory Tract Infection: A Cross-Sectional StudyJiaqi Meng, Weichang Yang, Ziyong Chen, et al.
JCI Insight|July 22, 2025
VEGFD/VEGFR2 axis induces the dedifferentiation of high endothelial venules and impairs lymphocyte homingWeichang Yang, Juan Wu, Shanshan Cai, et al.
Critical Reviews in Oncology/Hematology|September 16, 2023
Delta-like ligand 3 in small cell lung cancer: Potential mechanism and treatment progressWeichang Yang, Wenjun Wang, Zhouhua Li, et al.
Frontiers in Immunology|April 19, 2024
Tumor lymphangiogenesis index reveals the immune landscape and immunotherapy response in lung adenocarcinomaWeichang Yang, Zhijian Wu, Shanshan Cai, et al.
Frontiers in Genetics|June 23, 2023
Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinomaWeichang Yang, Zhouhua Li, Wenjun Wang, et al.
Frontiers in Cell and Developmental Biology|April 23, 2024
Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patientsZhouhua Li, Yue Wu, Weichang Yang, et al.
Acta Biomaterialia|July 27, 2024
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damageZhouhua Li, Xuehua Ma, Yanqiang Yang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Biological Macromolecules|May 11, 2026
Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infectionHongquan Xing, Shanshan Cai, Cong Wu, et al.
World Journal of Surgical Oncology|November 1, 2025
Primary tumor resection: a new hope or an old illusion for patients with metastatic non-small cell lung neuroendocrine tumors?Hongquan Xing, Weichang Yang, Shanshan Cai, et al.
Plos One|November 8, 2024
Clinical features and prognostic factors of IV combined small cell lung cancer: A propensity score matching analysisShanshan Cai, Weichang Yang, Hongdan Luo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2024
ApoA1, ApoB, ApoA1/B for Pathogenic Prediction of Chronic Obstructive Pulmonary Disease Complicated by Acute Lower Respiratory Tract Infection: A Cross-Sectional StudyJiaqi Meng, Weichang Yang, Ziyong Chen, et al.
JCI Insight|July 22, 2025
VEGFD/VEGFR2 axis induces the dedifferentiation of high endothelial venules and impairs lymphocyte homingWeichang Yang, Juan Wu, Shanshan Cai, et al.
Critical Reviews in Oncology/Hematology|September 16, 2023
Delta-like ligand 3 in small cell lung cancer: Potential mechanism and treatment progressWeichang Yang, Wenjun Wang, Zhouhua Li, et al.
Frontiers in Immunology|April 19, 2024
Tumor lymphangiogenesis index reveals the immune landscape and immunotherapy response in lung adenocarcinomaWeichang Yang, Zhijian Wu, Shanshan Cai, et al.
Frontiers in Genetics|June 23, 2023
Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinomaWeichang Yang, Zhouhua Li, Wenjun Wang, et al.
Frontiers in Cell and Developmental Biology|April 23, 2024
Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patientsZhouhua Li, Yue Wu, Weichang Yang, et al.
Acta Biomaterialia|July 27, 2024
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damageZhouhua Li, Xuehua Ma, Yanqiang Yang, et al.
Pageof 2